Icariin improves osteoporosis, inhibits the expression of PPARγ, C/EBPα, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats

Experimental and Therapeutic Medicine

Volumn 13, Issue 4, 2017, Pages 1360-1368

  Liu, Hengrui ^a   Xiong, Yingquan ^a   Zhu, Xiaofeng ^a   Gao, Han ^a   Yin, Sujuan ^a   Wang, Jiefang ^a   Chen, Guangming ^a   Wang, Chaopeng ^a   Xiang, Lu ^a   Wang, Panpan ^a   Fang, Ji ^a   Zhang, Ronghua ^a   Yang, Li ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Icariin; Notch; Osteoporosis

Indexed keywords

ALENDRONIC ACID; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID BINDING PROTEIN 4; ICARIIN; INHIBITOR OF DIFFERENTIATION PROTEIN; MESSENGER RNA; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN JAGGED 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITOMETRY; BONE TISSUE; CONTROLLED STUDY; DOWN REGULATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 85013755272     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.4128     Document Type: Article

References (42)

1. United States Food and Drug Association, Division of Metabolism and Endocrine Drug Products: Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Prevention or Treatment of Postmenopausal Osteoporosis. Food and Drug Administration, USA, 1997.
2. Cairoli E, Zhukouskaya VV, Eller-Vainicher C and Chiodini I: Perspectives on osteoporosis therapies. J Endocrinol Invest 38: 303-311, 2015.
3. An J, Yang H, Zhang Q, Liu C, Zhao J, Zhang L and Chen B: Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci 147: 46-58, 2016.
4. Indran IR, Liang RL, Min TE and Yong EL: Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health. Pharmacol Ther 162: 188-205, 2016.
5. Sze SC, Tong Y, Ng TB, Cheng CL and Cheung HP: Herba Epimedii: Anti-oxidative properties and its medical implications. Molecules 15: 7861-7870, 2010.
6. Guo J, Li F, Wu Q, Gong Q, Lu Y and Shi J: Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats. Phytomedicine 17: 950-955, 2010.
7. Li S, Dong P, Wang J, Zhang J, Gu J, Wu X, Wu W, Fei X, Zhang Z, Wang Y, et al: Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Lett 298: 222-230, 2010.
8. Zhou J, Wu J, Chen X, Fortenbery N, Eksioglu E, Kodumudi KN, Pk EB, Dong J, Djeu JY and Wei S: Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int Immunopharmacol 11: 890-898, 2011.
9. Wang Z, Zhang X, Wang H, Qi L and Lou Y: Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience 145: 911-922, 2007.
10. Yang L, Lu D, Guo J, Meng X, Zhang G and Wang F: Icariin from Epimedium brevicornum Maxim promotes the biosynthesis of estrogen by aromatase (CYP19). J Ethnopharmacol 145: 715-721, 2013.
11. Qin L, Han T, Zhang Q, Cao D, Nian H, Rahman K and Zheng H: Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. J Ethnopharmacol 118: 271-279, 2008.
12. Zhang G, Qin L, Sheng H, Yeung KW, Yeung HY, Cheung WH, Griffith J, Chan CW, Lee KM and Leung KS: Epimedium-derived phytoestrogen exert beneficial effect on preventing steroid-associated osteonecrosis in rabbits with inhibition of both thrombosis and lipid-deposition. Bone 40: 685-692, 2007.
13. Ye HY and Lou YJ: Estrogenic effects of two derivatives of icariin on human breast cancer MCF-7 cells. Phytomedicine 12: 735-741, 2005.
14. Yamaguchi M and Gao YH: Inhibitory effect of genistein on bone resorption in tissue culture. Biochem Pharmacol 55: 71-76, 1998.
15. Chen KM, Ge BF, Liu XY, Ma PH, Lu MB, Bai MH and Wang Y: Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie 62: 388-391, 2007.
16. Huang J, Yuan L, Wang X, Zhang TL and Wang K: Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci 81: 832-840, 2007.
17. Titorencu I, Pruna V, Jinga VV and Simionescu M: Osteoblast ontogeny and implications for bone pathology: An overview. Cell Tissue Res 355: 23-33, 2014.
18. Grogan SP, Olee T, Hiraoka K and Lotz MK: Repression of chon-drogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site. Arthritis Rheum 58: 2754-2763, 2008.
19. Nobta M, Tsukazaki T, Shibata Y, Xin C, Moriishi T, Sakano S, Shindo H and Yamaguchi A: Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1 activated Notch1 signaling. J Biol Chem 280: 15842-15848, 2005.
20. Garcés C, Ruiz-Hidalgo MJ, Font de Mora J, Park C, Miele L, Goldstein J, Bonvini E, Porrás A and Laborda J: Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem 272: 29729-29734, 1997.
21. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, et al: PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113: 846-855, 2004.
22. Teitelbaum SL: Osteoclasts: What do they do and how do they do it? Am J Pathol 170: 427-435, 2007.
23. Devlin H and Ferguson MW: Compositional changes in rat femur following ovariectomy. Acta Anat (Baslel) 136: 38-41, 1989.
24. Kalu DN: Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology 115: 507-512, 1984.
25. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-tie quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
26. Mok SK, Chen WF, Lai WP, Leung PC, Wang XL, Yao XS and Wong MS: Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol 159: 939-949, 2010.
27. Nan H, Ma MH, Nan SS and Xu LL: Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 16: 320-326, 2009.
28. Feng R, Feng L, Yuan Z, Wang D, Wang F, Tan B, Han S, Li T, Li D and Han Y: Icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo. Cell Biochem Biophys 67: 189-197, 2013.
29. Ma HP, Ming LG, Ge BF, Zhai YK, Song P, Xian CJ and Chen KM: Icarrin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem 112: 916-923, 2011.
30. Zhao J, Ohba S, Shinkai M, Chung UI and Nagamune T: Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner. Biochem Biophys Res Commun 369: 444-448, 2008.
31. Povoroznyuk Vladyslav V,; Nikonenko, Pavel I.; Grygoryeva, Natalija V. Bone 42; 1: S83-S83, 2008.
32. Peng S, Zhang G, He Y, Wang X, Leung P, Leung K and Qin L: Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone 45: 534-544, 2009.
33. Campa VM, Gutiérrez-Lanza R, Cerignoli F, Díaz-Trelles R, Nelson B, Tsuji T, Barcova M, Jiang W and Mercola M: Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. J Cell Biol 183: 129-141, 2008.
34. Augello A and De Bari C: The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther 21: 1226-1238, 2010.
35. Huang Y, Yang X, Wu Y, Jing W, Cai X, Tang W, Liu L, Liu Y, Grotkau BE and Lin Y: Gamma-secretase inhibitor induces adipogenesis of adipose-derived stem cells by regulation of Notch and PPAR-gamma. Cell Prolif 43: 147-156, 2010.
36. Bai S, Kopan R, Zou W, Hilton MJ, Ong CT, Long F, Ross FP and Teitelbaum SL: NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J Biol Chem 283: 6509-6518, 2008.
37. Fiúza UM and Arias AM: Cell and molecular biology of Notch. J Endocrinol 194: 459-474, 2007.
38. Weinmaster G: Notch signal transduction: A real rip and more. Curr Opin Genet Dev 10: 363-369, 2000.
39. Zanotti S, Smerdel-Ramoya A, Stadmeyer L, Durant D, Radtke F and Canalis E: Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology 149: 3890-3899, 2008.
40. Ugarte F, Ryser M, Thieme S, Fierro FA, Navratiel K, Bornhäuser M and Brenner S: Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol 37: 867-875.e1, 2009.
41. Kim HL, Sim JE, Choi HM,Choi IY, Jeong MY, Park J,Jung Y, Youn DH, Cho JH,Kim JH, et al: The AMPK pathway mediates an anti-adipogenic effect of fruits of Hovenia dulcis Thunb. Food Funct 5: 2961-2968, 2014.
42. Lewis J, Hanisch A and Holder M: Notch signaling, the segmentation clock, and the patterning of vertebrate somites. J Biol 8: 44, 2009.